Dr. Peter Marks is being forced to resign from the FDA because the Trump administration does not want someone who is ...

Peter Marks, the FDA’s top vaccine official ousted by Robert F. Kennedy Jr. said the U.S. health secretary’s team sought ...

Bullish option flow detected in Novavax (NVAX) with 12,673 calls trading, 2x expected, and implied vol increasing almost 14 points to 90.76%.

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...

Ousted FDA biologics and vaccine chief Peter Marks was asked to provide non-existent data on the risk from measles vaccines, ...